Loading publications…
The last 5 uploaded publications
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial
Pascal Vranckx, Marco Valgimigli, Peter Jüni, Christian W. Hamm, Philippe Gabríel Steg, Dik Heg, Gerrit Anne van Es, Eugène McFadden, Yoshinobu Onuma, Cokky van Meijeren, Ply Chichareon, Edouard Benit, Helge Möllmann, Luc Janssens, Maurizio Ferrario, Aris Moschovitis, Aleksander Żurakowski, Marcello Dominici, Robert‐Jan van Geuns, Kurt Huber, Ton Slagboom, Patrick W. Serruys, Stephan Windecker, Mohamed Abdellaoui, David Adlam, İbrahim Akın, Agustín Albarrán González-Trevilla, Manuel Almeida, Pedro A. Lemos, Adel Aminian, Richard Anderson, Rick Andreae, Michaël Angioı̈, Taku Asano, Emanuele Barbato, Peter Barlis, Pascal Barraud, Edouard Benit, Olivier F. Bertrand, Farzin Beygui, Leonardo Bolognese, Roberto Botelho, Coby Bouwman, Marco Bressers, Philippe Brunel, Paweł Buszman, Ian Buysschaert, Pedro Canas da Silva, Didier Carrié, Ángel Cequier, Ply Chichareon, Chun Chin Chang, Saqib Chowdhary, Carlos Collet, Antonio Colombo, James Cotton, Rui Cruz Ferreira, Salvatore Curello, Nick Curzen, Judith de Bot, Tone de Vreede, Georg Delle Karth, Lynn Dijksma, Marcello Dominici, István Édes, Éric Eeckhout, Ingo Eitel, József Faluközy, Farzin Fath‐Ordoubadi, Maurizio Ferrario, Géza Fontos, José Francisco Díaz Fernández, Edgard Freitas Quintella, Bernhard Frey, Guy Friedrich, Gavin Galasko, G. Gałuszka, Vasco Gama Ribeiro, Scot Garg, Giuseppe Gargiulo, Tobias Geisler, Валери Гелев, Art Ghandilyan, Javier Goicolea, Tommaso Gori, Felice Gragnano, Ana Guimarães, Christian W. Hamm, Michael Haude, Dik Heg, Pieter Heijke, Rosa Ana Hernández Antolín, David Hildick‐Smith, Dorien Hillen, Ina Hoekman, Sjoerd H. Hofma, Lene Holmvang, Stephen P. Hoole, Iván Horváth, Kurt Huber (2018). Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial. The Lancet, 392(10151), pp. 940-949, DOI: 10.1016/s0140-6736(18)31858-0.
Article146 days agoImpact of long-term ticagrelor monotherapy following 1-month dual antiplatelet therapy in patients who underwent complex percutaneous coronary intervention: insights from the Global Leaders trial
Patrick W. Serruys, Kuniaki Takahashi, Ply Chichareon, Norihiro Kogame, Mariusz Tomaniak, Rodrigo Modolo, Chun Chin Chang, Hidenori Komiyama, Osama Soliman, Joanna J. Wykrzykowska, Robbert J. de Winter, Maurizio Ferrario, Marcello Dominici, Paweł Buszman, Leonardo Bolognese, Carlo Tumscitz, Edouard Benit, Hans‐Peter Stoll, Christian W. Hamm, Philippe Gabríel Steg, Yoshinobu Onuma, Peter Jüni, Stephan Windecker, Pascal Vranckx, Antonio Colombo, Marco Valgimigli (2019). Impact of long-term ticagrelor monotherapy following 1-month dual antiplatelet therapy in patients who underwent complex percutaneous coronary intervention: insights from the Global Leaders trial. European Heart Journal, 40(31), pp. 2595-2604, DOI: 10.1093/eurheartj/ehz453.
Article146 days agoClinical Implication of Quantitative Flow Ratio After Percutaneous Coronary Intervention for 3-Vessel Disease
Norihiro Kogame, Kuniaki Takahashi, Mariusz Tomaniak, Ply Chichareon, Rodrigo Modolo, Chun Chin Chang, Hidenori Komiyama, Yuki Katagiri, Taku Asano, Rod Stables, Farzin Fath‐Ordoubadi, Simon Walsh, Manel Sabaté, Justin E. Davies, Jan J. Piek, Robert‐Jan van Geuns, Johan H. C. Reiber, Adrian Banning, Javier Escaned, Vasim Farooq, Patrick W. Serruys, Yoshinobu Onuma (2019). Clinical Implication of Quantitative Flow Ratio After Percutaneous Coronary Intervention for 3-Vessel Disease. КАРДИОЛОГИЯ УЗБЕКИСТАНА, 12(20), pp. 2064-2075, DOI: 10.1016/j.jcin.2019.08.009.
Article146 days agoSafety and efficacy of a sirolimus-eluting coronary stent with ultra-thin strut for treatment of atherosclerotic lesions (TALENT): a prospective multicentre randomised controlled trial
Azfar Zaman, Robbert J. de Winter, Norihiro Kogame, Chun Chin Chang, Rodrigo Modolo, Ernest Spitzer, Pim A.L. Tonino, Sjoerd H. Hofma, Aleksander Żurakowski, Pieter C. Smits, Janusz Prokopczuk, Raúl Moreno, Anirban Choudhury, Ivo Petrov, Ángel Cequier, Neville Kukreja, Angela Hoye, Andrés Íñiguez, Imre Ungi, Antonio Serra, Robert Gil, Simon Walsh, Gincho Tonev, Anthony Mathur, Béla Merkely, Antonio Colombo, Sander Ijsselmuiden, Osama Soliman, Upendra Kaul, Yoshinobu Onuma, Patrick W. Serruys (2019). Safety and efficacy of a sirolimus-eluting coronary stent with ultra-thin strut for treatment of atherosclerotic lesions (TALENT): a prospective multicentre randomised controlled trial. The Lancet, 393(10175), pp. 987-997, DOI: 10.1016/s0140-6736(18)32467-x.
Article146 days agoAngiography-Derived Fractional Flow Reserve in the SYNTAX II Trial
Taku Asano, Yuki Katagiri, Chun Chin Chang, Norihiro Kogame, Ply Chichareon, Kuniaki Takahashi, Rodrigo Modolo, Erhan Tenekecioğlu, Carlos Collet, Hans Jonker, Clare Appleby, Azfar Zaman, Nicolas M. Van Mieghem, Neal Uren, Javier Zueco, Jan J. Piek, Johan H. C. Reiber, Vasim Farooq, Javier Escaned, Adrian Banning, Patrick W. Serruys, Yoshinobu Onuma (2019). Angiography-Derived Fractional Flow Reserve in the SYNTAX II Trial. КАРДИОЛОГИЯ УЗБЕКИСТАНА, 12(3), pp. 259-270, DOI: 10.1016/j.jcin.2018.09.023.
Article146 days ago